Dr. Costantine Albany, MD
Claim this profileHorizon Oncology Research, LLC
Studies Cancer
Studies Melanoma
5 reported clinical trials
7 drugs studied
Area of expertise
1Cancer
EphA5 positive
Stage III
Stage IV
2Melanoma
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Costantine Albany, MD is currently running
INV-1120 + Pembrolizumab
for Advanced Cancer
Phase 1, open-label dose-escalation study to determine the MTD of INV-1120 and RP2D, and to assess the DLT of INV-1120 as a single agent or in the combination with pembrolizumab. The safety, tolerability, and PK of INV-1120 as a single agent or in the combination with pembrolizumab will be assessed in adult patients with advanced solid tumors.
Recruiting1 award Phase 110 criteria
BT8009 + Pembrolizumab
for Solid Tumors
This study is a Phase I/II, multicenter, first-in-human, open-label dose-escalation study of BT8009 given as a single agent and in combination with pembrolizumab in participants with advanced solid tumors associated with Nectin-4 expression or in participants with advanced solid tumor malignancies having renal insufficiency. The primary endpoints are: Dose limiting toxicities (Parts A-1 and A-2), Overall response rate per RECIST v1.1 (Parts B1-B7), Safety and tolerability (Parts B-8, B-9 and C), and characterization of the pharmacokinetics (Part D).
Recruiting1 award Phase 1 & 214 criteria
More about Costantine Albany, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Costantine Albany, MD has experience with
- Nivolumab
- Pembrolizumab
- MT-8421
- BT8009
- BA3071
- INV-1120
Breakdown of trials Costantine Albany, MD has run
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Costantine Albany, MD specialize in?
Costantine Albany, MD focuses on Cancer and Melanoma. In particular, much of their work with Cancer has involved EphA5 positive patients, or patients who are Stage III.
Is Costantine Albany, MD currently recruiting for clinical trials?
Yes, Costantine Albany, MD is currently recruiting for 5 clinical trials in Lafayette Indiana. If you're interested in participating, you should apply.
Are there any treatments that Costantine Albany, MD has studied deeply?
Yes, Costantine Albany, MD has studied treatments such as Nivolumab, Pembrolizumab, MT-8421.
What is the best way to schedule an appointment with Costantine Albany, MD?
Apply for one of the trials that Costantine Albany, MD is conducting.
What is the office address of Costantine Albany, MD?
The office of Costantine Albany, MD is located at: Horizon Oncology Research, LLC, Lafayette, Indiana 47905 United States. This is the address for their practice at the Horizon Oncology Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.